Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

María Reig

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Antioxidants (Basel, Switzerland)|September 28, 2021
Antioxidants Threaten Multikinase Inhibitor Efficacy against Liver Cancer by Blocking Mitochondrial Reactive Oxygen SpeciesBlanca Cucarull, Anna Tutusaus, Tania Hernáez-Alsina, et al.
Radiology and Oncology|July 1, 2022
Portal hypertension may influence the registration of hypointensity of small hepatocellular carcinoma in the hepatobiliary phase in gadoxetic acid MRCarla Caparroz, Alejandro Forner, Jordi Rimola, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 9, 2021
Incidence of Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-analysis, and Meta-regressionLorenzo A Orci, Marco Sanduzzi-Zamparelli, Berta Caballol, et al.
Acta Gastroenterologica Latinoamericana|February 25, 2010
[Twenty-four weeks therapy with peginterferon alfa-2a could be similar to 48 weeks therapy in patients with HBeAg positive chronic hepatitis B and good predictors of response: results of a pilot study]Joaquín Solari, Omar Galdame, Lucrecia Rezzonico, et al.
European Radiology|March 7, 2025
Diagnostic performance of contrast-enhanced US in small liver nodules not conclusively characterized after MRI in cirrhotic patientsBelén Saborido, Anna Darnell, Alejandro Forner, et al.
Abdominal Radiology (New York)|July 9, 2025
Reproducibility and accuracy of non-contrast abbreviated magnetic resonance imaging of the liver in surveillance for early recurrence for hepatocellular carcinoma in a Western population: a multi-reader studyJordi Rimola, Belén Saborido, Alba Igual, et al.
Hepatology (Baltimore, Md.)|June 1, 2010
Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasoundRamón Vilana, Alejandro Forner, Luis Bianchi, et al.
Cancers|April 27, 2024
Induction of the Inflammasome Pathway by Tyrosine Kinase Inhibitors Provides an Actionable Therapeutic Target for Hepatocellular CarcinomaAnna Tutusaus, Marco Sanduzzi-Zamparelli, Loreto Boix, et al.
Cancers|July 2, 2021
The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma?Ester Gonzalez-Sanchez, Javier Vaquero, Maite G Férnandez-Barrena, et al.
Journal of Hepatology|June 26, 2024
Histological predictors of aggressive recurrence of hepatocellular carcinoma after liver resectionCarla Fuster-Anglada, Ezequiel Mauro, Joana Ferrer-Fàbrega, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Antioxidants (Basel, Switzerland)|September 28, 2021
Antioxidants Threaten Multikinase Inhibitor Efficacy against Liver Cancer by Blocking Mitochondrial Reactive Oxygen SpeciesBlanca Cucarull, Anna Tutusaus, Tania Hernáez-Alsina, et al.
Radiology and Oncology|July 1, 2022
Portal hypertension may influence the registration of hypointensity of small hepatocellular carcinoma in the hepatobiliary phase in gadoxetic acid MRCarla Caparroz, Alejandro Forner, Jordi Rimola, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 9, 2021
Incidence of Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-analysis, and Meta-regressionLorenzo A Orci, Marco Sanduzzi-Zamparelli, Berta Caballol, et al.
Acta Gastroenterologica Latinoamericana|February 25, 2010
[Twenty-four weeks therapy with peginterferon alfa-2a could be similar to 48 weeks therapy in patients with HBeAg positive chronic hepatitis B and good predictors of response: results of a pilot study]Joaquín Solari, Omar Galdame, Lucrecia Rezzonico, et al.
European Radiology|March 7, 2025
Diagnostic performance of contrast-enhanced US in small liver nodules not conclusively characterized after MRI in cirrhotic patientsBelén Saborido, Anna Darnell, Alejandro Forner, et al.
Abdominal Radiology (New York)|July 9, 2025
Reproducibility and accuracy of non-contrast abbreviated magnetic resonance imaging of the liver in surveillance for early recurrence for hepatocellular carcinoma in a Western population: a multi-reader studyJordi Rimola, Belén Saborido, Alba Igual, et al.
Hepatology (Baltimore, Md.)|June 1, 2010
Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasoundRamón Vilana, Alejandro Forner, Luis Bianchi, et al.
Cancers|April 27, 2024
Induction of the Inflammasome Pathway by Tyrosine Kinase Inhibitors Provides an Actionable Therapeutic Target for Hepatocellular CarcinomaAnna Tutusaus, Marco Sanduzzi-Zamparelli, Loreto Boix, et al.
Cancers|July 2, 2021
The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma?Ester Gonzalez-Sanchez, Javier Vaquero, Maite G Férnandez-Barrena, et al.
Journal of Hepatology|June 26, 2024
Histological predictors of aggressive recurrence of hepatocellular carcinoma after liver resectionCarla Fuster-Anglada, Ezequiel Mauro, Joana Ferrer-Fàbrega, et al.
Pageof 7